GLP1_PBM_Rebate_Exposer

Audits PBM contracts and GLP-1 claims data to expose how rebate structures force near-list manufacturer sell-in pricing, quantify PBM spread, and generate a hard-math ROI report that advocates for direct-to-pharmacy or direct-to-patient models using transparent or Cost Plus pricing to recover enterprise margin.